Transcriptional Activity of Tumour Necrosis Factor α (TNF‐α) in Patients with Subclinical Coronary Atherosclerosis – Preliminary Results Cited by

Fol. Biol. 2012, 58, 209-214

https://doi.org/10.14712/fb2012058050209

Transcriptional Activity of Tumour Necrosis Factor α (TNF‐α) in Patients with Subclinical Coronary Atherosclerosis – Preliminary Results

J. Dąbek¹, R. Świderski¹, Joanna Głogowska-Ligus², P. Pysz¹

¹Department of Cardiology, Medical University of Silesia in Katowice, Poland
²Department of Epidemiology, Medical University of Silesia in Katowice, Poland

Received March 2012
Accepted April 2012

Crossref Cited-by Linking

Kazemi Elaheh, Jamialahmadi Khadijeh, Avan Amir, Mirhafez Seyed Reza, Mohiti Javad, Pirhoushiaran Maryam, Hosseini Nedasadat, Mohammadi Akram, Ferns Gordon A., Pasdar Alireza, Ghayour\u2010Mobarhan Majid: Association of tumor necrosis factor\u2010\u03b1 \u2010308 G/A gene polymorphism with coronary artery diseases: An evidence\u2010based study. Clinical Laboratory Analysis 2018, 32. <https://doi.org/10.1002/jcla.22153>
Assiri Adel M. A., El-Baz Hatim A., Amin Ali H.: Tumor necrosis factor inhibition increases the revascularization of ischemic hind-limbs in diabetic mice. Naunyn-Schmiedeberg's Arch Pharmacol 2015, 388, 1053. <https://doi.org/10.1007/s00210-015-1138-x>